Table 3.
Variable | Group (Mean Change) | p a | Difference in Mean Change (Standardized) | |
---|---|---|---|---|
>SG (n = 20) | PG (n = 16) | |||
Zone 1 (m) | −21.8 ± 26.3 | −11.9 ± 43.1 | 0.429 | −9.9, −35.2–15.5 (−0.28, −1.00–0.44) |
Zone 2 (m) | −55.9 ± 95.3 | −49.6 ± 65.0 | 0.816 | −6.3, −60.8–48.2 (−0.10, −0.98–0.78) |
Zone 3 (m) | 234 ± 182 | 227 ± 228 | 0.918 | 7, −136–150 (0.04, −0.67–0.74) |
Zone 4 (m) | 30.9 ± 188 | −37.1 ± 172 | 0.266 | 67.9, −54.2–190.0 (0.36, −0.29–1.00) |
Zone 5 (m) | 13.5 ± 23.2 | 12.2 ± 20.7 | 0.864 | 1.3, 13.6–16.1 (0.07, −0.80–0.95) |
Zone 1 (%) | −1.9 ± 1.5 | −1.3 ± 2.7 | 0.398 | −0.7, −2.2–0.9 (−0.19, −0.65–0.27) |
Zone 2 (%) | −4.6 ± 5.3 | −4.2 ± 5.0 | 0.834 | −0.4, −3.8–3.1 (−0.08, −0.81–0.66) |
Zone 3 (%) | 7.2 ± 6.0 | 8.6 ± 8.6 | 0.595 | −1.4, −6.6–3.8 (−0.17, −0.82–0.48) |
Zone 4 (%) | −1.4 ± 6.5 | −3.5 ± 7.4 | 0.370 | 2.2, −2.7–7.0 (−0.30, −0.30–0.79) |
Zone 5 (%) | 0.55 ± 1.10 | 0.50 ± 0.73 | 0.871 | 0.1, −0.6–0.7 (0.05, −0.63–0.74) |
SSG (m) | 61.6 ± 40 | 41.2 ± 48.2 | 0.184 | 20.4, −10.3–51.1 (0.43, −0.22–1.09) |
HRSSG (beats/min) | −2.6 ± 5.5 | −3.0 ± 6.2 | 0.855 | 0.4, −3.7–4.4 (0.06, −0.58–0.69) |
a the t-test for unequal variances; PG—placebo group, un-supplemented; SG—supplemented with vitamin D; for difference in mean change and standardized (with pre-training SD) difference in mean, 95% confidence limits are shown.